UBS Oracle · ORCL

UBS Raises Oracle Price Target to $285

Analyst: Karl Keirstead 1 min read Reproduced verbatim
Rating
Buy
Target
$285
from $250 (+14%)
Upside
+147%
ORCL at $115 today
UBS and Oracle logos

What the analyst said

UBS analyst Karl Keirstead raised the price target on Oracle (NYSE: ORCL) to $285.00 (from $250.00) while maintaining a Buy rating.

“Ahead of Oracle’s 4Q/May quarter presumably next week, we preview what we think are the key investor topics and likely FY27 commentary, as well as offer unvarnished feedback from four large customers and partners and one contractor with visibility into the big Abilene, TX, AI data center build-out.

Bottom line, we did not pick up evidence of any set-back in momentum and at 27x CY27 non-GAAP EPS, we remain Buy-rated on Oracle shares and constructive on the broader “long-hyperscaler” trade.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

ORCL trades at $115. The 22 analysts who set a target in the last 3 months range from $155 to $400, with a median of $233. This $285 target is 23% above the median.

Since the note ORCL has moved −54% (from $248). 12-month window: day 157 of 365, closes on June 2, 2027.

Track record

This callOpen: ORCL has not reached $285 yet. This 12-month target is scored on June 2, 2027.

Firm track recordUBS: 81% of its 54 targets at least a year old were reached within 12 months (#9 of 26 firms). Accuracy ranking →

UBS on Oracle

UBS price targets on Oracle

6 calls from January 5, 2026 to September 11, 2026. The target went from $280 to $250 (−11%). The rating stayed Buy.

UBS targetORCL share price
  1. September 11, 2026Target raised from $245 (+2%)Buy$250
  2. August 6, 2026Target cut from $285 (−14%)Buy$245
  3. June 2, 2026 This noteTarget raised from $250 (+14%)Buy$285
  4. April 7, 2026Kept the $250 targetBuy$250
  5. February 2, 2026Target cut from $280 (−11%)Buy$250
  6. January 5, 2026Earliest call shownBuy$280
Share

Other analysts on Oracle

ScotiabankBuy Cut price target −5%, kept rating Oct 29 $205from $215 GuggenheimBuy Kept rating and price target Oct 29 $400maintained OppenheimerBuy Kept rating and price target Oct 29 $275maintained BairdBuy Kept rating and price target Oct 29 $215maintained Melius ResearchBuy Kept rating and price target Oct 29 $170maintained
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.